<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Angiogenic factors are critical to the initiation of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and maintenance of the vascular network </plain></SENT>
<SENT sid="1" pm="."><plain>Here we use human genetics as an approach to identify an angiogenic factor, VG5Q, and further define two genetic defects of VG5Q in patients with the <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> <z:e sem="disease" ids="C0022739" disease_type="Disease or Syndrome" abbrv="KTS">Klippel-Trenaunay syndrome (KTS)</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>One mutation is chromosomal translocation t(5;11), which increases VG5Q transcription </plain></SENT>
<SENT sid="3" pm="."><plain>The second is mutation E133K identified in five <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">KTS</z:e> patients, but not in 200 matched controls </plain></SENT>
<SENT sid="4" pm="."><plain>VG5Q protein acts as a potent angiogenic factor in promoting <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and suppression of VG5Q expression inhibits vessel formation </plain></SENT>
<SENT sid="5" pm="."><plain>E133K is a functional mutation that substantially enhances the angiogenic effect of VG5Q </plain></SENT>
<SENT sid="6" pm="."><plain>VG5Q shows strong expression in blood vessels and is secreted as vessel formation is initiated </plain></SENT>
<SENT sid="7" pm="."><plain>VG5Q can bind to endothelial cells and promote cell proliferation, suggesting that it may act in an autocrine fashion </plain></SENT>
<SENT sid="8" pm="."><plain>We also demonstrate a direct interaction of VG5Q with another secreted angiogenic factor, TWEAK (also known as TNFSF12) </plain></SENT>
<SENT sid="9" pm="."><plain>These results define VG5Q as an angiogenic factor, establish VG5Q as a susceptibility gene for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">KTS</z:e>, and show that <z:mp ids='MP_0005601'>increased angiogenesis</z:mp> is a molecular pathogenic mechanism of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">KTS</z:e> </plain></SENT>
</text></document>